Baird Jennifer A
Transaction: 07/01/2026
BUY
Change
+4,000
Price
Not reported
Filing
07/02/2026
Type
BUY
SeaStar Medical Holding Corporation
ICU • Biotechnology
$2.98
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$119.25M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 3.63Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:38 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.98
Change0.00%
Shares Out40.02M
Market Cap$119.25M
Enterprise Value$112.42M
52W Range2.07 - 12.50
Beta-1.04
P/E-8.75
P/S69.61
P/B27.76
P/FCF-8.71
EV/Sales65.63
Price$2.98
Change0.00%
Shares Out40.02M
Market Cap$119.25M
Enterprise Value$112.42M
52W Range2.07 - 12.50
Beta-1.04
P/E-8.75
P/S69.61
P/B27.76
P/FCF-8.71
EV/Sales65.63
EV/EBITDA-8.17
EV/FCF-8.21
Earnings Yield-11.43%
FCF Yield-11.48%
Dividend Yield0.00%
Gross Margin95.71%
Oper. Margin-9.87%
Profit Margin-9.85%
Debt/Eq0.05
Current Ratio3.63
Quick Ratio3.61
Target$8.00
Target Upside168.47%
Target Median$8.00
Target Range8.00 - 8.00
Volume94.57K
Avg Volume103.58K
EPS Surprise-0.17
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
42/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 3.63Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$8.00
Mean
$8.00
Median
$8.00
High
$8.00
Insider Transactions
Recent executive and insider activity
Van Heel Kenneth
Transaction: 07/01/2026
BUY
Change
+4,000
Price
Not reported
Filing
07/02/2026
Type
BUY
Neuman John
Transaction: 07/01/2026
BUY
Change
+4,000
Price
Not reported
Filing
07/02/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Baird Jennifer A | BUY | +4,000 | Not reported | 07/01/2026 | 07/02/2026 |
| Van Heel Kenneth | BUY | +4,000 | Not reported | 07/01/2026 | 07/02/2026 |
| Neuman John | BUY | +4,000 | Not reported | 07/01/2026 | 07/02/2026 |
| Vincent Bernadette N | BUY | +4,000 | Not reported | 07/01/2026 | 07/02/2026 |
| Chung Kevin | BUY | +7,202 | Not reported | 07/01/2026 | 07/02/2026 |
| Schlorff Eric | BUY | +10,288 | Not reported | 07/01/2026 | 07/02/2026 |
| Schlorff Eric | BUY | +30,000 | Not reported | 02/06/2026 | 02/10/2026 |
| Chung Kevin | BUY | +15,000 | Not reported | 02/06/2026 | 02/10/2026 |
| Towne Bradford K | BUY | +7,500 | Not reported | 02/06/2026 | 02/10/2026 |
| Baird Jennifer A | BUY | +3,000 | Not reported | 02/06/2026 | 02/10/2026 |
| Vincent Bernadette N | BUY | +3,000 | Not reported | 02/06/2026 | 02/10/2026 |
| Neuman John | BUY | +3,000 | Not reported | 02/06/2026 | 02/10/2026 |
| Van Heel Kenneth | BUY | +3,000 | Not reported | 02/06/2026 | 02/10/2026 |
| Baird Jennifer A | BUY | +4,200 | $0.24 | 12/19/2025 | 12/22/2025 |
| Messinger Michael | BUY | +14,500 | $0.35 | 12/09/2025 | 12/11/2025 |
| Messinger Michael | OTHER | 0 | Not reported | 11/14/2025 | 12/08/2025 |
| Towne Bradford K | OTHER | 0 | Not reported | 08/26/2025 | 09/09/2025 |
| Van Heel Kenneth | BUY | +10,000 | $0.86 | 08/27/2025 | 08/28/2025 |
| Van Heel Kenneth | BUY | +25,000 | $0.89 | 08/26/2025 | 08/28/2025 |
| Chung Kevin | BUY | +10,000 | $0.80 | 08/22/2025 | 08/25/2025 |